---
title: "Swasti Vinayaka Art & Heritage Corporation Ltd (512257) — Share Price, Financials & Analysis"
symbol: "512257"
company: "Swasti Vinayaka Art & Heritage Corporation Ltd"
canonical: "https://tapetide.com/stocks/512257"
isin: "INE895A01023"
nse_symbol: "SWASTIVINAYAKAARTHERITAGECORPLTD"
bse_code: "512257"
sector: "Diversified"
industry: "Diversified Group"
market_cap_cr: 30.82
generated_at: "2026-09-13T19:39:37.877Z"
---

# Swasti Vinayaka Art & Heritage Corporation Ltd (512257)

Canonical page: https://tapetide.com/stocks/512257

## Company

- **NSE Symbol:** SWASTIVINAYAKAARTHERITAGECORPLTD
- **BSE Code:** 512257
- **ISIN:** INE895A01023
- **Sector:** Diversified
- **Industry:** Diversified Group
- **Macro Sector:** Diversified
- **Stock Type:** EQUITY
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** swastivinayakaart.co.in

## About

Incorporated in 1985, Swasti Vinayaka Art and Heritage Corporation Ltd is engaged in the manufacturing of artifacts consisting 
of a collection of gemstone sculptures, real estate, and stocks.[1]

## Latest Price

## Key Fundamentals

Observed at 2026-09-11T04:41:38.151150Z.

- **Market Cap:** ₹30.82 Cr
- **Classification:** Microcap
- **P/E (reported):** 6.3
- **EPS (TTM):** ₹0.55
- **EPS (reported):** ₹0.18
- **Book Value:** ₹3.5
- **Price to Book:** 0.98
- **Dividend Yield:** 0%
- **ROE:** 8.75%
- **ROCE:** 9.93%
- **Debt to Equity:** 0.26
- **Revenue (yearly):** ₹31.7 Cr
- **Net Income:** ₹5.83 Cr
- **EBITDA:** ₹7.88 Cr
- **52-Week High:** ₹4.84
- **52-Week Low:** ₹2.82
- **RSI (14):** 48.59

## Tapetide Score

- **Score:** 57 / 100
- **Score date:** 2026-09-04
- **Archetype:** Out of Favour
- **What it means:** Financially sound, yet the market is not rewarding it. Cases like this usually need a specific reason the pessimism is misplaced, and patience for that reason to play out.
- **Pillar profile:** Quality: Good · Valuation: Cheap · Momentum: Falling
- **Percentile:** 77.8 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 56.39 | 9% |
| growth | 50 | 9% |
| momentum | 29.05 | 12% |
| ownership | 50 | 24% |
| quality | 64.55 | 22% |
| valuation | 71.29 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.
- Stock is trading at 0.97 times its book value
- Company's working capital requirements have reduced from 409 days to 140 days

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 13.3% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -172.39% | -459.26% | -204.3% |
| ebitda margin growth | -74.36% | -1.2% | -27.19% | -18.61% |
| net income growth | -78.57% | 153.48% | 26% | 28% |
| revenue growth | -65.6% | 59.3% | 36% | 30% |
| roce | — | 10.95% | -29.22% | 10.9% |
| roe | — | 3.8% | 10.64% | -26.72% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3.14 | 3.03 | 3.32 | 5.19 | 6.92 | 3.3 | 3.49 | 9.96 | 3.67 | 6.33 | 11.74 | 4.11 |
| Expenses | 1.93 | 1.9 | 2.85 | 4.81 | 5.74 | 2.52 | 2.01 | 7.56 | 2.57 | 5.15 | 8.57 | 3.34 |
| Operating Profit | 1.21 | 1.13 | 0.47 | 0.38 | 1.18 | 0.78 | 1.48 | 2.4 | 1.1 | 1.18 | 3.17 | 0.77 |
| OPM % | 38.54 | 37.29 | 14.16 | 7.32 | 17.05 | 23.64 | 42.41 | 24.1 | 29.97 | 18.64 | 27 | 18.73 |
| Other Income | 0.1 | 0.11 | 0.28 | 0.17 | 0.25 | 0.3 | 0.24 | 0.12 | 0.3 | 0.24 | 0.72 | 0.22 |
| Interest | 0.21 | 0.28 | 0.66 | 0.38 | 0.39 | 0.41 | 0.63 | 0.56 | 0.37 | 0.32 | 0.25 | 0.21 |
| Depreciation | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.03 | 0.02 |
| Profit before tax | 1.07 | 0.93 | 0.06 | 0.15 | 1.01 | 0.64 | 1.06 | 1.94 | 1.01 | 1.08 | 3.61 | 0.76 |
| Tax % | 24.3 | 23.66 | 66.67 | 20 | 24.75 | 26.56 | 10.38 | 24.74 | 23.76 | 23.15 | 23.82 | 23.68 |
| Net Profit | 0.81 | 0.7 | 0.02 | 0.11 | 0.77 | 0.48 | 0.95 | 1.45 | 0.77 | 0.83 | 2.75 | 0.58 |
| EPS in Rs | 0.09 | 0.08 | 0 | 0.01 | 0.09 | 0.05 | 0.11 | 0.16 | 0.09 | 0.09 | 0.31 | 0.06 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 9.72 | 9.07 | 9.46 | 8.49 | 10.03 | 12.67 | 12.38 | 18.9 | 31.7 | 25.85 |
| Expenses | 5.24 | 5.99 | 6.8 | 5.14 | 7.3 | 8.14 | 8.7 | 15.06 | 23.82 | 19.63 |
| Operating Profit | 4.48 | 3.08 | 2.66 | 3.35 | 2.73 | 4.53 | 3.68 | 3.84 | 7.88 | 6.22 |
| OPM % | 46.09 | 33.96 | 28.12 | 39.46 | 27.22 | 35.75 | 29.73 | 20.32 | 24.86 | 24.06 |
| Other Income | 0.02 | 0.07 | 0.22 | 0.26 | 0.28 | 0.31 | 0.56 | 0.95 | 1.37 | 1.48 |
| Interest | 0.71 | 0.78 | 0.91 | 0.94 | 0.79 | 0.79 | 1.39 | 1.81 | 1.49 | 1.15 |
| Depreciation | 0.3 | 0.29 | 0.3 | 0.24 | 0.18 | 0.14 | 0.11 | 0.1 | 0.09 | 0.09 |
| Profit before tax | 3.49 | 2.08 | 1.67 | 2.43 | 2.04 | 3.91 | 2.74 | 2.88 | 7.67 | 6.46 |
| Tax % | 30.37 | 28.37 | 28.74 | 26.75 | 25 | 25.06 | 25.18 | 19.44 | 24.25 | — |
| Net Profit | 2.43 | 1.5 | 1.2 | 1.78 | 1.53 | 2.93 | 2.05 | 2.32 | 5.81 | 4.93 |
| EPS in Rs | 0.27 | 0.17 | 0.13 | 0.2 | 0.17 | 0.33 | 0.23 | 0.26 | 0.65 | 0.55 |
| Dividend Payout % | 32.92 | 53.33 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4 | 4 | 4 | 4 | 4 | 4 | 9 | 9 | 9 | 9 |
| Reserves | 5.49 | 6.98 | 8.3 | 7.97 | 10.9 | 12.92 | 10.85 | 15.26 | 17.47 | 22.5 |
| Borrowings | 6.11 | 5.21 | 7.86 | 8.62 | 8.2 | 7.1 | 7.3 | 14.71 | 13.89 | 8.11 |
| Other Liabilities | 7.28 | 7.77 | 6.28 | 9.07 | 9.23 | 9.73 | 9.44 | 8.97 | 11.22 | 12.5 |
| Total Liabilities | 22.88 | 23.96 | 26.44 | 29.66 | 32.33 | 33.75 | 36.59 | 47.94 | 51.58 | 52.11 |
| Fixed Assets | 1.58 | 1.6 | 2.39 | 2.45 | 2.22 | 2.06 | 1.93 | 1.84 | 1.77 | 18.3 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0.23 | 0.57 | 0.95 | 1.6 | 3.63 | 4.46 | 4.76 | 7.27 | 12.6 | 0 |
| Other Assets | 21.07 | 21.79 | 23.1 | 25.61 | 26.48 | 27.23 | 29.9 | 38.83 | 37.21 | 33.81 |
| Total Assets | 22.88 | 23.96 | 26.44 | 29.66 | 32.33 | 33.75 | 36.59 | 47.94 | 51.58 | 52.11 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1.57 | 3.18 | 0.69 | 2.44 | 1.86 | 1.96 | 0.54 | 2.68 | -1.94 | 18.24 |
| Cash from Investing Activity | -0.36 | -0.62 | -1.58 | -1.37 | -0.52 | -0.09 | 0.02 | 0.39 | -4.52 | -3.37 |
| Cash from Financing Activity | -1.09 | -2.58 | 0.9 | -1.12 | -1.35 | -1.92 | -0.57 | 6.02 | -2.64 | 0 |
| Net Cash Flow | 0.12 | -0.01 | 0.01 | -0.05 | -0.01 | -0.05 | -0.01 | 9.08 | -9.1 | 14.87 |
| Free Cash Flow | 1.35 | 2.86 | -0.39 | 2.12 | 1.97 | 1.94 | 0.54 | 2.66 | -1.97 | 17.82 |
| CFO/OP | 58 | 100 | 52 | 121 | 70 | 72 | 12 | 73 | -51 | 231 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 17.36 | 12.77 | 12.48 | 23.54 | 58.04 | 18.92 | 8.07 | 4.72 | 1.16 | 19.46 |
| Inventory Days | — | — | — | — | — | — | — | — | 1260.61 | 602.27 |
| Days Payable | — | — | — | — | — | — | — | — | 23.85 | 3.31 |
| Cash Conversion Cycle | 17.36 | 12.77 | 12.48 | 23.54 | 58.04 | 18.92 | 8.07 | 4.72 | 1237.92 | 618.42 |
| Working Capital Days | 432.79 | 452.87 | 452.73 | 426.73 | 647.89 | 515.29 | 547.64 | 643.03 | 442.63 | 140.13 |
| ROCE % | 32.25 | 26.42 | 15.46 | 12.47 | 14.79 | 11.5 | 18.25 | 12.46 | 11.67 | 22.91 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% | 51% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Government | 0% | 0.16% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 44.96% | 45.02% | 45.17% | 44.99% | 44.55% | 44.28% | 44.22% | 44.13% | 44.18% | 43.87% | 43.78% | 44.1% |
| Others | 4.04% | 3.82% | 3.83% | 4.01% | 4.45% | 4.72% | 4.78% | 4.87% | 4.82% | 5.13% | 5.22% | 4.9% |
| No. of Shareholders | 19931 | 25350 | 33011 | 33645 | 33436 | 37861 | 38486 | 37301 | 36800 | 35720 | 34738 | 34190 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 2 / 7 / 10

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 3.42 | Sell |
| EMA (10) | 3.42 | Sell |
| SMA (20) | 3.39 | Sell |
| EMA (20) | 3.44 | Sell |
| SMA (50) | 3.53 | Sell |
| EMA (50) | 3.51 | Sell |
| SMA (100) | 3.6 | Sell |
| EMA (100) | 3.56 | Sell |
| SMA (200) | 3.58 | Sell |
| EMA (200) | 3.62 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 44.94 | Neutral |
| MACD (12,26,9) | -0.03 | Buy |
| Stochastic (14,3,3) | 46.26 | Neutral |
| ADX (14) | 18.27 | Neutral |
| Williams %R (14) | -61.22 | Neutral |
| ATR (14) | 0.22 | High Volatility |
| ROC (12) | 4.64 | Buy |
| Stoch RSI (14) | 63.36 | Neutral |
| UO (7,14,28) | 36.57 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=994403c8-e4b9-4711-982a-b6bacb0c7e3c.pdf) |
| 2026-09-05 | [Notice Of The 40Th Annual General Meeting Of The Company For Financial Year 2025-26.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ae3963c-56a4-47f3-9a36-2fcbbc3dd561.pdf) |
| 2026-09-05 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=26ae17d6-1194-4e35-9d51-c7235d64b1c8.pdf) |
| 2026-09-05 | [Letter To Members Pursuant To Regulation 30 Read With 36(1)(B) Of SEBI (LODR) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60cb28b1-9003-4d41-a182-76e24ee38bad.pdf) |
| 2026-08-29 | [Board Meeting Outcome for Board Meeting Outcome For The Meeting Held On Saturday August 29 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=decf4c7a-1ade-465f-a726-1eef4539d866.pdf) |
| 2026-08-29 | [Annual General Meeting To Be Held On Monday September 28 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1400edf-c1cc-461b-b321-48089ded5fea.pdf) |
| 2026-08-29 | [Intimation Of Book Closure For 40Th Annual General Meeting.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=56698b04-032f-407f-a708-42130d170988.pdf) |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=75e433fb-cd61-4b67-b271-4785daa3fa67.pdf) |
| 2026-08-14 | [Board Meeting Outcome for The Meeting Held On Friday August 14 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=23dea229-4c7a-4ee6-a218-f27fc81eb609.pdf) |
| 2026-08-07 | [Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter Ended On June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3bb89671-4570-422a-8d57-8f879b9b3f5a.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-14 | [Submission Of Unaudited Financial Results For The Quarter Ended June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=060bdfc0-1b55-4218-bfdb-bcb15606bceb.pdf) |
| 2026-06-20 | [Resubmission Of Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60963aba-7a2a-4577-be97-33da4e95b789.pdf) |
| 2026-05-30 | [Audited Financial Results For The Fourth Quarter And Financial Year Ended March 31 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fe48c046-8e43-4f44-a5c1-dd685b8ff133.pdf) |
| 2026-02-13 | [Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended On December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed3040ae-4fa0-4b33-8ca1-5e2e1041db02.pdf) |
| 2025-11-14 | [Submission Of Un-Audited Financial Results For The Quarter And Half Year Ended On September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea7a74b7-06c7-4c73-b4d1-88322c9bc8c1.pdf) |
| 2025-08-14 | [Submission Of Un-Audited Financial Results For The Quarter Ended On June 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=18dd1448-fb51-46a9-9112-8c97680229bf.pdf) |
| 2025-05-28 | [Audited Financial Results For The Quarter And Financial Year Ended On March 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=808ca090-6d44-4e8f-9a0b-6d65878bb066.pdf) |
| 2025-01-21 | [Un-Audited Financial Results For The Quarter And Nine Months Ended On December 31 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9ba1d8eb-28de-4db0-9aec-de977a3576ba.pdf) |
| 2024-11-14 | [Un-Audited Financial Results For The Quarter And Half Year Ended On September 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1a99bf27-29e4-4222-919d-e1b04f62d5ae.pdf) |
| 2024-08-09 | [Un-Audited Financial Results For The Quarter Ended On June 30, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d02a993d-fc9c-400e-81a8-728a2f5832ee.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 February 2026 - ₹47.52 Cr biggest-ever order; new Khanna plant raises capacity to 180,000 MT; merger proposal discussed. | [Press Release 9 February 2026 - ₹47.52 Cr biggest-ever order; new Khanna plant raises capacity to 180,000 MT; merger proposal discussed.](https://nsearchives.nseindia.com/corporate/AJOONI_09022026105608_Press_Release_update.pdf) |
| 9 February 2026 - ₹47.52 Cr biggest-ever order; Khanna plant commissioned; capacity 1,80,000 MT; 9M revenue ₹122.87Cr. | [Press Release 9 February 2026 - ₹47.52 Cr biggest-ever order; Khanna plant commissioned; capacity 1,80,000 MT; 9M revenue ₹122.87Cr.](https://nsearchives.nseindia.com/corporate/AJOONI_09022026110001_Press_Release_update.pdf) |
| 9 Feb - Board meeting Feb 13, 2026 to consider unaudited Q3 and nine-month results for period ended Dec 31, 2025. | [Board Meeting Intimation for Considering And Approving Un-Audited Financial Results For The Quarter And Nine Months Ended On December 31, 2025 9 Feb - Board meeting Feb 13, 2026 to consider unaudited Q3 and nine-month results for period ended Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/14d09dde-07b5-465f-8f3c-3812e7b065a0.pdf) |
| 6 February 2026 - Received Rs. 47.52 crore cattle feed order on Feb 6, 2026. | [General Updates 6 February 2026 - Received Rs. 47.52 crore cattle feed order on Feb 6, 2026.](https://nsearchives.nseindia.com/corporate/AJOONI_06022026120342_AJOONI__UpdateNSE_4752CRORE_final.pdf) |
| 6 February 2026 - Ajooni Biotech received Rs.47.52 crore cattle feed order; announced 06-Feb-2026. | [General Updates 6 February 2026 - Ajooni Biotech received Rs.47.52 crore cattle feed order; announced 06-Feb-2026.](https://nsearchives.nseindia.com/corporate/AJOONI_06022026120733_AJOONI__UpdateNSE_4752CRORE_final.pdf) |
| 30 January 2026 - Approved unaudited financials for quarter ended Dec 31, 2025; merger with Healthy Biosciences deferred. | [Outcome of Board Meeting 30 January 2026 - Approved unaudited financials for quarter ended Dec 31, 2025; merger with Healthy Biosciences deferred.](https://nsearchives.nseindia.com/corporate/AJOONI_30012026120836_Outcome_results_ajooni_300125_sd.pdf) |
| 27 Apr - Company confirms non-applicability of large corporate debt disclosure norms for FY2025-26. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 27 Apr - Company confirms non-applicability of large corporate debt disclosure norms for FY2025-26.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6805150f-ed23-449b-8c39-15a7e28e8022.pdf) |
| 14 Feb - Copies of newspaper publications of the Un-Audited Financial Results for the Quarter and Nine Months ended December 31, 2025, approved at the Meeting of the … | [Announcement under Regulation 30 (LODR)-Newspaper Publication 14 Feb - Copies of newspaper publications of the Un-Audited Financial Results for the Quarter and Nine Months ended December 31, 2025, approved at the Meeting of the …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/04cdddc6-1763-42d5-bb02-e200ed6c7fb2.pdf) |
| 13 Feb - Unaudited results for quarter/nine months ended 31-Dec-2025: Q3 net profit 83.25, 9M net profit 305.32 | [Board Meeting Outcome for The Meeting Held On Friday, February 13, 2026 13 Feb - Unaudited results for quarter/nine months ended 31-Dec-2025: Q3 net profit 83.25, 9M net profit 305.32](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f84d83e5-c0f6-4468-9c6f-1aa050ab0e1e.pdf) |
| 13 Feb - Unaudited Q3 and 9M FY2026 results (31 Dec 2025): 9M revenue Rs2,061.48, 9M net profit Rs305.32. | [Submission Of Un-Audited Financial Results For The Quarter And Nine Months Ended On December 31, 2025. 13 Feb - Unaudited Q3 and 9M FY2026 results (31 Dec 2025): 9M revenue Rs2,061.48, 9M net profit Rs305.32.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ed3040ae-4fa0-4b33-8ca1-5e2e1041db02.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://nsearchives.nseindia.com/corporate/AJOONI_05102024152255_Ajooni_investorpresentation_Final_sd.pdf) |
| May 2024 | [Concall - May 2024](https://nsearchives.nseindia.com/corporate/AJOONI_08052024084125_Update_InvestorPresentation_08052024.pdf) |
| May 2024 | [Concall - May 2024](https://nsearchives.nseindia.com/corporate/AJOONI_24052024144933_ABL_InvestorPresentation_sd.pdf) |
| Jun 2022 | [Concall - Jun 2022](https://archives.nseindia.com/corporate/AJOONI_29062022103815_Ajooni_Investorpresentation_Final.pdf) |
| Jan 2025 | [Concall - Jan 2025](https://nsearchives.nseindia.com/corporate/AJOONI_09012025122552_Ajooni_Biotech_Presentation__Q2FY25_090125.pdf) |
| Feb 2021 | [Concall - Feb 2021](https://archives.nseindia.com/corporate/AJOONI_25022021144009_NSE_Investorpresentation250221.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/AR_27942_AJOONI_2024_2025_A_2487139_30082025135729.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/AR_24981_AJOONI_2023_2024_1708202413229.pdf) |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/AR_22675_AJOONI_2022_2023_07082023141937_08072023150000.zip) |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/AR_20894_AJOONI_2021_2022_27082022103939_08272022110001.zip) |
| from nse | [Financial Year 2021 from nse](https://archives.nseindia.com/annual_reports/AR_18987_AJOONI_2020_2021_28082021142620_08282021150004.zip) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/978fae3a-27a8-49a0-8845-bf7b8fbc886c.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/24e642ae-60d6-4f09-bccb-687aa4b95620.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2f8e0091-d0c8-450a-93fe-acc338d180d6.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/512257/73100512257.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/512257/70493512257.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:39:37.877Z.